Skip To Main Content
Yonwaba Mzizi on Muck Rack

Yonwaba Mzizi

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yonwaba

Contact Yonwaba, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Development of 225 Ac PSMA617-TFA Poly(Lactic-co-glycolic)acid Nanoparticles and Their Potential Use in Targeted Alpha Therapy

|
By Bwalya A. Witika, Honest Ndlovu, Yonwaba Mzizi
| preprints.org
You are already at the latest version Background: Actinium-225 (225Ac) is receiving major attention as the radionuclide of choice for targeted alpha therapy (TAT) due to its outstanding physical properties such as a long physical half-life of 9.9 days and a short range of alpha (α)- particles which are responsible for the destruction of malignant tumours, whilst sparing normal surrounding tissues.
Open in Who Shared Issue with article?
See all 1 articles